Lv66
2560 积分 2021-10-11 加入
Is rituximab retro in mantle cell lymphoma?
9天前
已完结
Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma
9天前
已完结
Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials
19天前
已完结
Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China
19天前
已完结
Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis
19天前
已完结
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data
26天前
已完结
Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial
1个月前
已完结
Design, synthesis, and antiproliferative evaluation of novel longifolene-derived tetraline pyrimidine derivatives with fluorescence properties
1个月前
已完结
Comment on “Subcutaneous administration of cytarabine for pediatric patients with Langerhans cell histiocytosis decreases burden of patient travel and infusion center utilization”
1个月前
已完结
Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis
2个月前
已完结
皖公网安备34019202002308
